Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Centrifugation of Harvested Broth in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Centrifugation of Harvested Broth in Bioreactor Operations – V 2.0


Standard Operating Procedure for Centrifugation of Harvested Broth in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/087/2025
Supersedes SOP/BS/087/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for centrifuging harvested culture broth from bioreactor operations during biosimilar manufacturing, with the aim of separating biomass and collecting clarified supernatant for downstream processing.

2. Scope

This SOP applies to all large-scale bioreactor harvests from mammalian or microbial cultures that require cell removal through centrifugation prior to filtration or purification.

3. Responsibilities

  • Production Operator: Execute centrifugation as per batch instructions and monitor run parameters.
  • Maintenance Engineer: Ensure centrifuge calibration, balancing, and operational readiness.
  • QA Officer: Review centrifuge logs and ensure compliance with GMP documentation.

4. Accountability

The Production Head is accountable for verifying that centrifugation is performed as per defined parameters and ensuring safe operation of equipment and transfer of supernatant.

5. Procedure

5.1 Equipment Preparation

  1. Verify cleanliness status of centrifuge and attach “Ready for Use” status tag.
  2. Check rotor integrity, seals, and absence of residue or contamination.
  3. Ensure that collection containers and transfer lines are sanitized and labeled with batch details.

5.2 Loading Harvested Broth

  1. Connect feed line from harvest tank to centrifuge inlet under aseptic conditions.
  2. Prime lines using 0.9% saline or WFI (if applicable).
  3. Ensure vessel volume and loading balance as per capacity guidelines (e.g., max 400 L per cycle for swing-bucket rotor).

5.3 Centrifugation Parameters

  1. Set speed: 4000–6000 rpm (depending on cell type and centrifuge model).
  2. Run time: 10–20 minutes per cycle.
  3. Set temperature: 4°C for mammalian cells, ambient for microbial cultures.
  4. Program automatic braking and acceleration curves to minimize cell disruption.

5.4 Supernatant Collection

  1. After each run, transfer clear supernatant to the clarified harvest tank using sterile connection.
  2. Label collection tank with:
    • Product name
    • Batch number
    • Date and time of harvest
  3. Take a 10 mL sample and send to QC for turbidity and bioburden check.

5.5 Post-Centrifugation Activities

  1. Flush the centrifuge bowl and rotor with WFI and inspect for residual cells.
  2. Record all operational parameters in Annexure-1: Centrifugation Log.
  3. Initiate cleaning SOP post-harvest cycle or before product changeover.

6. Abbreviations

  • rpm: Revolutions Per Minute
  • QC: Quality Control
  • WFI: Water for Injection
  • GMP: Good Manufacturing Practice

7. Documents

  1. Centrifugation Log – Annexure-1

8. References

  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • WHO TRS 1025 Annex 2 – GMP for Biotech Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Centrifugation Log

Date Batch No. Cycle No. Volume (L) Speed (rpm) Time (min) Temperature (°C) Operator
04/05/2025 BS-087-B02 1 400 5000 15 4 Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added specific centrifuge settings and bioburden sample collection Process Clarification
See also  Biosimilars: SOP for Endotoxin Removal in Bacterial Systems - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: BA-BE Studies: SOP for Partial and Failed Analytical Runs – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Formulation Development of Intramuscular Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version